Health Secretary Tom Price’s Investment Portfolio Has Directly Benefited From His Pharma Agenda

Before he was named Trump’s health secretary, Price took a congressional trip to Australia and pressed officials to extend protections for drug companies in an international trade agreement.

Read the full article at: feedproxy.google.com